GGrantIndex
← Leaderboards

Ian H De Boer

University Of Washington

$19,396,846
Attributed
$25,234,300
Total exposure
10
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY201025
$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$25,234,300 · 10

By mechanism

R01$23,460,690 · 7
U01$810,823 · 1
UH2$562,787 · 1
RC4$400,000 · 1

Top collaborators

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Trials

Research focus

Clinical TrialsMeasurementKidneyRisk FactorsBaseEventCohortCardiovascular DiseasesCessation Of LifeGlomerular Filtration RateCardiovascular SystemPersonsPreventUrineMetabolismParticipantCardiovascular Disorder RiskInflammationPrematureHigh RiskVitamin DMorbidity - Disease RateSerumLaboratories

Grant awards (45)

Blood Sugar Sensing on Maintenance Dialysis$813,671
R01 · FY2025 · DK · contact PI
KPMP in Type 1 Diabetes: A UW Medicine Collaboration$810,823
U01 · FY2025 · DK
Pathogenesis of kidney disease in type 1 diabetes: a modern kidney biopsy cohort$606,603
R01 · FY2025 · DK · contact PI
Pathogenesis of kidney disease in type 1 diabetes: a modern kidney biopsy cohort$558,239
R01 · FY2024 · DK · contact PI
Kidney Tubular Functions in Type 1 Diabetes$656,434
R01 · FY2023 · DK · contact PI
Hypoglycemia and glycemic control in patients treated with dialysis$638,685
R01 · FY2023 · DK · contact PI
Pathogenesis of kidney disease in type 1 diabetes: a modern kidney biopsy cohort$591,182
R01 · FY2023 · DK · contact PI
Hypoglycemia and glycemic control in patients treated with dialysis$644,159
R01 · FY2022 · DK · contact PI
Kidney Tubular Functions in Type 1 Diabetes$640,903
R01 · FY2022 · DK · contact PI
Pathogenesis of kidney disease in type 1 diabetes: a modern kidney biopsy cohort$639,223
R01 · FY2022 · DK · contact PI
Kidney Tubular Functions in Type 1 Diabetes$645,215
R01 · FY2021 · DK · contact PI
Hypoglycemia and glycemic control in patients treated with dialysis$644,159
R01 · FY2021 · DK · contact PI
Kidney Tubular Functions in Type 1 Diabetes$722,130
R01 · FY2020 · DK · contact PI
Hypoglycemia and glycemic control in patients treated with dialysis$636,109
R01 · FY2020 · DK · contact PI
Randomized trial of vitamin D and omega-3 fatty acids for diabetic kidney disease$484,233
R01 · FY2019 · DK · contact PI
Individual response to vitamin D treatment$416,092
R01 · FY2019 · HL
Individual response to vitamin D treatment$733,529
R01 · FY2018 · HL
Randomized trial of vitamin D and omega-3 fatty acids for diabetic kidney disease$724,496
R01 · FY2018 · DK · contact PI
Vitamin D Catabolism in Chronic Kidney Disease$528,513
R01 · FY2018 · DK · contact PI
Vitamin D Catabolism in Chronic Kidney Disease$155,000
R01 · FY2018 · DK · contact PI
Individual response to vitamin D treatment$752,620
R01 · FY2017 · HL
Randomized trial of vitamin D and omega-3 fatty acids for diabetic kidney disease$718,107
R01 · FY2017 · DK · contact PI
Vitamin D Catabolism in Chronic Kidney Disease$565,857
R01 · FY2017 · DK · contact PI
Individual response to vitamin D treatment$792,176
R01 · FY2016 · HL
Randomized trial of vitamin D and omega-3 fatty acids for diabetic kidney disease$746,026
R01 · FY2016 · DK · contact PI
Vitamin D Catabolism in Chronic Kidney Disease$632,426
R01 · FY2016 · DK · contact PI
Vitamin D Catabolism in Chronic Kidney Disease$656,045
R01 · FY2015 · DK · contact PI
Vitamin D Catabolism in Chronic Kidney Disease$699,401
R01 · FY2014 · DK · contact PI
Pragmatic Randomized Trial of Calcitriol in Patients with Chronic Kidney Disease$562,787
UH2 · FY2014 · HL
Randomized trial of vitamin D and omega-3 fatty acids for diabetic kidney disease$338,619
R01 · FY2014 · DK · contact PI
Randomized trial of vitamin D and omega-3 fatty acids for diabetic kidney disease$112,311
R01 · FY2014 · DK · contact PI
Phosphorus and Vitamin D Metabolism and Cardiovascular Outcomes: The MESA Study$484,835
R01 · FY2013 · HL
Randomized trial of vitamin D and omega-3 fatty acids for diabetic kidney disease$328,611
R01 · FY2013 · DK · contact PI
Insulin Resistance in Chronic Kidney Disease$277,295
R01 · FY2013 · DK · contact PI
Insulin Resistance in Chronic Kidney Disease$146,736
R01 · FY2013 · DK · contact PI
Phosphorus and Vitamin D Metabolism and Cardiovascular Outcomes: The MESA Study$512,075
R01 · FY2012 · HL
Insulin Resistance in Chronic Kidney Disease$480,744
R01 · FY2012 · DK · contact PI
Randomized trial of vitamin D and omega-3 fatty acids for diabetic kidney disease$341,441
R01 · FY2012 · DK · contact PI
Phosphorus and Vitamin D Metabolism and Cardiovascular Outcomes: The multi-ethni$770,072
R01 · FY2011 · HL
Insulin Resistance in Chronic Kidney Disease$441,159
R01 · FY2011 · DK · contact PI
Randomized trial of vitamin D and omega-3 fatty acids for diabetic kidney disease$378,692
R01 · FY2011 · DK · contact PI
Phosphorus and Vitamin D Metabolism and Cardiovascular Outcomes: The multi-ethni$779,970
R01 · FY2010 · HL
Insulin Resistance in Chronic Kidney Disease$543,095
R01 · FY2010 · DK · contact PI
Randomized trial of vitamin D and omega-3 fatty acids for diabetic kidney disease$483,802
R01 · FY2010 · DK · contact PI
Vitamin D metabolism and type 1 diabetes complications$400,000
RC4 · FY2010 · DK · contact PI